I'm happy to do so. Thank you for the question.
The NRC has research on two tracks, both of which I think are responsive to your question and useful in the defence and dual-use space.
On the one side, we are doing research on medical countermeasures. This is vaccines and other biologics. We have capabilities and facilities that allow us to do the research right from the lab scale, up through producing sufficient quantities for clinical trials and then moving into commercial-scale production, in which we own but don't operate the biologics manufacturing centre. That full end-to-end capability, we think, is going to help Canadian companies take some of these advances in biologics all the way through to seeing them in use in our Canadian Armed Forces, but equally in the civilian sector as well.
On the other side, we have programs in medical devices, which have both civilian and defence uses. In particular, when you think about rapid diagnosis by our Canadian Armed Forces, especially in remote locations, there's significant interest there. Of course, it has use in civilian applications throughout our north and other more remote locations.